CWM
CTKB icon

CIBC World Markets’s Cytek Biosciences CTKB Stock Holding History

CIBC World Markets’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$49.3K Sell
14,487
-11,942
-45% -$39.8K ﹤0.01% 1473
2025
Q1 		$106K Buy
26,429
+15,071
+133% +$78.1K ﹤0.01% 1590
2024
Q4 		$73.7K Buy
+11,358
New +$67.7K ﹤0.01% 1244

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

CIBC World Markets's CTKB Position: Q2 2025 in Review

CIBC World Markets reduced its Cytek Biosciences (CTKB) stake by 45% in Q2 2025, selling an estimated $39.8K and leaving 14,487 shares worth $49.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1473.

CIBC World Markets first reported a position in CTKB in Q4 2024 and has held it in 3 quarters since. The position peaked at $106K in Q1 2025. 158 funds tracked by Wall St. Rank hold CTKB as of Q2 2025.

  • CIBC World Markets held 14,487 shares of Cytek Biosciences worth $49.3K as of Q2 2025.
  • CIBC World Markets sold 11,942 Cytek Biosciences shares in Q2 2025, an estimated $39.8K.
  • Cytek Biosciences made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1473 holding.
  • CIBC World Markets first reported a position in Cytek Biosciences in Q4 2024 and has held it in 3 quarters since.
  • CIBC World Markets's Cytek Biosciences position peaked at $106K in Q1 2025.
  • 158 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.